AMBU A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 110.6 DKK | +2.60% |
|
+1.14% | +5.09% |
| Apr. 12 | Nordic Stocks Rose Friday; BioArctic Series B Climbed Highest | DJ |
| Apr. 11 | U.S. Futures Down, European Stocks Mixed | DJ |
Valuation
| Fiscal Period: September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 27,812 | 44,622 | 48,168 | 16,876 | 19,669 | 29,440 | - | - |
| Enterprise Value (EV) 1 | 28,847 | 45,975 | 48,927 | 18,534 | 20,096 | 29,635 | 29,280 | 28,897 |
| P/E ratio | 88.7 x | 186 x | 194 x | 180 x | 115 x | 74.2 x | 48.9 x | 36.4 x |
| Yield | 0.33% | 0.16% | 0.15% | - | - | 0.31% | 0.45% | 0.71% |
| Capitalization / Revenue | 9.86 x | 12.5 x | 12 x | 3.8 x | 4.12 x | 5.57 x | 4.92 x | 4.33 x |
| EV / Revenue | 10.2 x | 12.9 x | 12.2 x | 4.17 x | 4.21 x | 5.61 x | 4.89 x | 4.25 x |
| EV / EBITDA | 49 x | 75.5 x | 88 x | 43.8 x | 31.8 x | 32.9 x | 24.5 x | 19.6 x |
| EV / FCF | 105 x | -346 x | -203 x | -40.5 x | 105 x | 91 x | 67.5 x | 53.5 x |
| FCF Yield | 0.95% | -0.29% | -0.49% | -2.47% | 0.96% | 1.1% | 1.48% | 1.87% |
| Price to Book | 12.6 x | 18.8 x | 12.2 x | 3.91 x | 3.69 x | 5.14 x | 4.73 x | 4.42 x |
| Nbr of stocks (in thousands) | 245,042 | 247,902 | 253,717 | 254,074 | 266,302 | 266,302 | - | - |
| Reference price 2 | 113.5 | 180.0 | 189.8 | 66.42 | 73.86 | 110.6 | 110.6 | 110.6 |
| Announcement Date | 11/13/19 | 11/11/20 | 11/9/21 | 11/15/22 | 11/8/23 | - | - | - |
1DKK in Million2DKK
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 2,820 | 3,567 | 4,013 | 4,444 | 4,775 | 5,283 | 5,982 | 6,794 |
| EBITDA 1 | 589 | 609 | 556 | 423 | 632 | 902 | 1,194 | 1,472 |
| EBIT 1 | 480 | 428 | 340 | 122 | 302 | 541.7 | 797.3 | 1,058 |
| Operating Margin | 17.02% | 12% | 8.47% | 2.75% | 6.32% | 10.25% | 13.33% | 15.57% |
| Earnings before Tax (EBT) 1 | 413 | 322 | 308 | 109 | 210 | 511.4 | 776.9 | 1,048 |
| Net income 1 | 317 | 241 | 247 | 93 | 168 | 397.7 | 603.7 | 815.3 |
| Net margin | 11.24% | 6.76% | 6.15% | 2.09% | 3.52% | 7.53% | 10.09% | 12% |
| EPS 2 | 1.280 | 0.9700 | 0.9800 | 0.3700 | 0.6400 | 1.489 | 2.261 | 3.037 |
| Free Cash Flow 1 | 274 | -133 | -241 | -458 | 192 | 325.5 | 433.8 | 540.3 |
| FCF margin | 9.72% | -3.73% | -6.01% | -10.31% | 4.02% | 6.16% | 7.25% | 7.95% |
| FCF Conversion (EBITDA) | 46.52% | - | - | - | 30.38% | 36.09% | 36.34% | 36.72% |
| FCF Conversion (Net income) | 86.44% | - | - | - | 114.29% | 81.85% | 71.85% | 66.28% |
| Dividend per Share 2 | 0.3800 | 0.2900 | 0.2900 | - | - | 0.3458 | 0.4965 | 0.7837 |
| Announcement Date | 11/13/19 | 11/11/20 | 11/9/21 | 11/15/22 | 11/8/23 | - | - | - |
1DKK in Million2DKK
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: September | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 1,026 | 1,031 | 1,122 | 1,128 | 1,163 | 1,132 | 1,189 | 1,195 | 1,259 | 1,254 | 1,289 | 1,329 | 1,401 |
| EBITDA 1 | 65 | 102 | 125 | 119 | 77 | 145 | 125 | 173 | 189 | 213 | 207 | 215 | 249 |
| EBIT 1 | 4 | 40 | 47 | 42 | -7 | 68 | 46 | 91 | 97 | 126 | 120 | 130 | 163 |
| Operating Margin | 0.39% | 3.88% | 4.19% | 3.72% | -0.6% | 6.01% | 3.87% | 7.62% | 7.7% | 10.05% | 9.31% | 9.78% | 11.63% |
| Earnings before Tax (EBT) 1 | -2 | 25 | 182 | 34 | -132 | 28 | 19 | 63 | 100 | 120 | 116 | 125 | 160 |
| Net income 1 | -1 | 20 | 175 | 28 | -130 | 22 | 15 | 51 | 80 | 92 | 89.6 | 97.2 | 124 |
| Net margin | -0.1% | 1.94% | 15.6% | 2.48% | -11.18% | 1.94% | 1.26% | 4.27% | 6.35% | 7.34% | 6.95% | 7.31% | 8.85% |
| EPS 2 | - | 0.0800 | 0.6900 | 0.1100 | -0.5100 | 0.0900 | 0.0600 | 0.1900 | 0.3000 | 0.3500 | 0.3400 | 0.3700 | 0.4700 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/9/21 | 2/8/22 | 5/5/22 | 8/25/22 | 11/15/22 | 2/7/23 | 5/3/23 | 8/31/23 | 11/8/23 | 1/30/24 | - | - | - |
1DKK in Million2DKK
Estimates
Balance Sheet Analysis
| Fiscal Period: September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 1,035 | 1,353 | 759 | 1,658 | 427 | 195 | - | - |
| Net Cash position 1 | - | - | - | - | - | - | 159 | 543 |
| Leverage (Debt/EBITDA) | 1.757 x | 2.222 x | 1.365 x | 3.92 x | 0.6756 x | 0.2162 x | - | - |
| Free Cash Flow 1 | 274 | -133 | -241 | -458 | 192 | 326 | 434 | 540 |
| ROE (net income / shareholders' equity) | 16% | 10.6% | 7.81% | 2% | 3% | 7.16% | 10% | 12.4% |
| ROA (Net income/ Total Assets) | 7.21% | 5.08% | 4.63% | 1.44% | 2.39% | 5.45% | 8.31% | 10.5% |
| Assets 1 | 4,396 | 4,742 | 5,333 | 6,478 | 7,037 | 7,301 | 7,266 | 7,783 |
| Book Value Per Share 2 | 9.000 | 9.570 | 15.60 | 17.00 | 20.00 | 21.50 | 23.40 | 25.00 |
| Cash Flow per Share 2 | 2.120 | 1.190 | 1.300 | 0.3700 | 1.920 | 2.400 | 3.000 | 3.800 |
| Capex 1 | 259 | 428 | 569 | 553 | 326 | 366 | 427 | 458 |
| Capex / Sales | 9.18% | 12% | 14.18% | 12.44% | 6.83% | 6.92% | 7.14% | 6.73% |
| Announcement Date | 11/13/19 | 11/11/20 | 11/9/21 | 11/15/22 | 11/8/23 | - | - | - |
1DKK in Million2DKK
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
110.6
DKK
Average target price
107.2
DKK
Spread / Average Target
-3.03%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +5.09% | 4.22B | |
| -2.31% | 187B | |
| -3.20% | 106B | |
| -5.04% | 66.9B | |
| +0.20% | 49.45B | |
| +17.29% | 48B | |
| +4.06% | 40.84B | |
| +2.36% | 26.25B | |
| +2.07% | 26.48B | |
| +12.96% | 24.62B |
- Stock Market
- Equities
- AMBU B Stock
- Financials Ambu A/S
